Figure 1

Demographics, treatments and responses for the sitagliptin intolerant and tolerant groups. Treatments were metformin (Met), sulfonylureas (SU) and insulin. (* Cases 16 and 18 were treated with chronic low dose methotrexate for rheumatoid arthritis. ^† Case 7 died of a pulmonary embolism, and Case 24 had a sudden unexplained death. n.d., not determined.)